Comment
. 2008 Nov;63(11):1026; author reply 1026.
Is the coprescription of beta blockers and beta2 agonists justified in COPD?
- PMID: 18984821
Item in Clipboard
Comment
Is the coprescription of beta blockers and beta2 agonists justified in COPD?
Thorax.
2008 Nov.
No abstract available
Comment on
-
Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.Thorax. 2008 Apr;63(4):301-5. doi: 10.1136/thx.2007.081893. Epub 2007 Oct 19. Thorax. 2008. PMID: 17951276
Similar articles
-
Use of beta-blockers in patients with COPD.Ann Pharmacother. 2004 Jan;38(1):142-5. doi: 10.1345/aph.1D113. Ann Pharmacother. 2004. PMID: 14742808 Review.
-
[Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].Pol Merkur Lekarski. 2008 Feb;24(140):121-4. Pol Merkur Lekarski. 2008. PMID: 18637263 Review. Polish.
-
Use of beta blockers in patients with COPD.Thorax. 2008 Apr;63(4):296-8. doi: 10.1136/thx.2007.091280. Thorax. 2008. PMID: 18364440 No abstract available.
-
Biases in the observational study of beta blockers in COPD.Thorax. 2008 Nov;63(11):1026-7; author reply 1027. Thorax. 2008. PMID: 18984819 No abstract available.
-
Pulmonary effects of nebivolol.Ther Adv Cardiovasc Dis. 2009 Aug;3(4):329-34. doi: 10.1177/1753944709339968. Ther Adv Cardiovasc Dis. 2009. PMID: 19638367 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
